337 related articles for article (PubMed ID: 26678086)
1. Clinicopathological and prognostic significance of chemokine receptor CXCR4 in patients with bone and soft tissue sarcoma: a meta-analysis.
Li YJ; Dai YL; Zhang WB; Li SJ; Tu CQ
Clin Exp Med; 2017 Feb; 17(1):59-69. PubMed ID: 26678086
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and prognostic significance of PD-L1 expression in sarcoma: A systematic review and meta-analysis.
Zheng C; You W; Wan P; Jiang X; Chen J; Zheng Y; Li W; Tan J; Zhang S
Medicine (Baltimore); 2018 Jun; 97(25):e11004. PubMed ID: 29923984
[TBL] [Abstract][Full Text] [Related]
3. Chemokine receptor CXCR4 expression is correlated with VEGF expression and poor survival in soft-tissue sarcoma.
Oda Y; Tateishi N; Matono H; Matsuura S; Yamamaoto H; Tamiya S; Yokoyama R; Matsuda S; Iwamoto Y; Tsuneyoshi M
Int J Cancer; 2009 Apr; 124(8):1852-9. PubMed ID: 19107931
[TBL] [Abstract][Full Text] [Related]
4. Bone versus soft-tissue sarcomas in the elderly.
Torigoe T; Terakado A; Suehara Y; Kurosawa H; Yazawa Y; Takagi T
J Orthop Surg (Hong Kong); 2010 Apr; 18(1):58-62. PubMed ID: 20427836
[TBL] [Abstract][Full Text] [Related]
5. One-year mortality in patients with bone and soft tissue sarcomas as an indicator of delay in presentation.
Nandra R; Hwang N; Matharu GS; Reddy K; Grimer R
Ann R Coll Surg Engl; 2015 Sep; 97(6):425-33. PubMed ID: 26274756
[TBL] [Abstract][Full Text] [Related]
6. Down-regulated E-cadherin expression is associated with poor five-year overall survival in bone and soft tissue sarcoma: results of a meta-analysis.
Wang N; He YL; Pang LJ; Zou H; Liu CX; Zhao J; Hu JM; Zhang WJ; Qi Y; Li F
PLoS One; 2015; 10(3):e0121448. PubMed ID: 25822802
[TBL] [Abstract][Full Text] [Related]
7. Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma.
Morimoto Y; Ozaki T; Ouchida M; Umehara N; Ohata N; Yoshida A; Shimizu K; Inoue H
Cancer; 2003 Nov; 98(10):2245-50. PubMed ID: 14601095
[TBL] [Abstract][Full Text] [Related]
8. The clinical prognostic significance of ezrin in patients with bone and soft tissue sarcomas: a meta-analysis.
Wang F; Yu T; Ma C; Zhang H; Zhang Z
FEBS Open Bio; 2019 Oct; 9(10):1744-1755. PubMed ID: 31376222
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of clinicopathological characteristics and prognostic factors of foot and ankle soft tissue and bone tumors].
Zhang XX; Xu LB; Xu SF; Zhao ZG; Liu T; Zhang SG; Yu SJ
Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):685-689. PubMed ID: 30293395
[No Abstract] [Full Text] [Related]
10. Clinicopathological and prognostic significance of chemokine receptor CXCR4 overexpression in patients with esophageal cancer: a meta-analysis.
Wu J; Wu X; Liang W; Chen C; Zheng L; An H
Tumour Biol; 2014 Apr; 35(4):3709-15. PubMed ID: 24326770
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography (18)F-fluorodeoxyglucose uptake and prognosis in patients with bone and soft tissue sarcoma: A meta-analysis.
Li YJ; Dai YL; Cheng YS; Zhang WB; Tu CQ
Eur J Surg Oncol; 2016 Aug; 42(8):1103-14. PubMed ID: 27189833
[TBL] [Abstract][Full Text] [Related]
12. [Molecular diagnosis of routine sarcomas].
Coindre JM
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S64-5. PubMed ID: 18984305
[No Abstract] [Full Text] [Related]
13. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis.
Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R
Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942
[TBL] [Abstract][Full Text] [Related]
14. Clinical and prognostic significance of PD-1 and PD-L1 expression in sarcomas.
Paydas S; Bagir EK; Deveci MA; Gonlusen G
Med Oncol; 2016 Aug; 33(8):93. PubMed ID: 27421997
[TBL] [Abstract][Full Text] [Related]
15. Sarcomas of Soft Tissue and Bone.
Ferrari A; Dirksen U; Bielack S
Prog Tumor Res; 2016; 43():128-41. PubMed ID: 27595362
[TBL] [Abstract][Full Text] [Related]
16. CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients.
Sand LG; Scotlandi K; Berghuis D; Snaar-Jagalska BE; Picci P; Schmidt T; Szuhai K; Hogendoorn PC
Eur J Cancer; 2015 Nov; 51(17):2624-33. PubMed ID: 26428435
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis.
Qiu L; Xu Y; Xu H; Yu B
BMC Cancer; 2022 Jun; 22(1):681. PubMed ID: 35729596
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma.
Vaynrub M; Taheri N; Ahlmann ER; Yao C; Fedenko AN; Allison DC; Chawla SP; Menendez LR
J Surg Oncol; 2015 Feb; 111(2):152-7. PubMed ID: 25175933
[TBL] [Abstract][Full Text] [Related]
19. Grb2-associated binding protein-1 as a biomarker in bone and soft tissue sarcomas.
Al-Husseinawi E; Bui MM; Ahmed AA
Pathology; 2019 Oct; 51(6):610-614. PubMed ID: 31443923
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and impact of surgery in patients with metastatic soft tissue sarcoma at diagnosis: A population-based cohort study.
Zhang L; Akiyama T; Fukushima T; Iwata S; Tsuda Y; Takeshita K; Kawai A; Tanaka S; Kobayashi H
Jpn J Clin Oncol; 2021 May; 51(6):918-926. PubMed ID: 33774673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
